TrialJournal of clinical psychopharmacology2011

Effects of the cannabinoid-1 receptor antagonist rimonabant on psychiatric symptoms in overweight people with schizophrenia: a randomized, double-blind, pilot study.

Deanna L Kelly et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.